Nerve damage from chemo may affect cancer survivors for years

January 15, 2016

(HealthDay)—Many women who survive cancer have symptoms of chemotherapy-related nerve damage in their feet and hands years after treatment, a new study reveals.

Moreover, this nerve damage—called chemotherapy-induced peripheral neuropathy—is associated with an increased risk of falls, the study found.

"We can't dismiss neuropathy as a treatment side effect that goes away, because persist for years in nearly half of women," said lead author Kerri Winters-Stone, a research professor at Oregon Health and Science University in Portland.

The study included 462 women who had survived —including breast, lung, colon, ovarian or blood cancers. At an average of six years after cancer diagnosis, 45 percent of them still had symptoms of nerve damage, such as loss of feeling in their hands and feet.

These symptoms were associated with much poorer physical functioning and difficulty doing daily tasks, such as cooking and shopping. The women with symptoms also had changes in their walking patterns and were nearly twice as likely to fall as those without such symptoms, the researchers discovered.

Falls can cause broken bones and other injuries, and possibly lead to earlier death, the study authors explained.

The study was to be presented Saturday at the American Society of Clinical Oncology (ASCO) meeting in San Francisco.

"While there are no effective treatments for this side effect, rehabilitative exercise programs may preserve physical functioning and mobility in the presence of neuropathy to help prevent falls and resulting injuries," Winters-Stone said in a society news release.

ASCO spokesperson Dr. Merry-Jennifer Markham said chemo-induced peripheral neuropathy is an often under-recognized symptom among cancer survivors.

The findings of studies like this "will allow us to improve and tailor rehabilitation as needed," Markham said in the news release.

Male cancer survivors are as likely as to have chemotherapy-induced , the researchers said.

Data and conclusions presented at meetings are usually considered preliminary until published in a peer-reviewed medical journal.

Explore further: Lymphoma survivors may not get all recommended follow-up care

More information: The U.S. National Institute of Neurological Disorders and Stroke has more about peripheral neuropathy.

Related Stories

Lymphoma survivors may not get all recommended follow-up care

January 15, 2016
(HealthDay)—Some teen and young adult survivors of Hodgkin lymphoma do not receive all the recommended follow-up care, a new study finds.

International panel recommends new model for breast cancer care

April 20, 2012
As the number of breast cancer survivors increases, now estimated at 2.8 million, more will be living with the chronic effects of cancer treatments or with advanced disease. An international panel of experts, including a ...

YouTube videos on peripheral nerve pain may misguide patients

October 21, 2015
Researchers who combed YouTube for videos regarding peripheral neuropathy, or nerve damage that causes weakness, numbness, and pain in the hands and feet, found 200 videos, but only about half of them were from healthcare ...

Researchers identify gene variations that predict chemotherapy side effects

April 9, 2013
Seemingly benign differences in genetic code from one person to the next could influence who develops side effects to chemotherapy, a Mayo Clinic study has found. The study identified gene variations that can predispose people ...

Study identifies method for detecting latent stage of lymphedema

December 18, 2015
Many are aware that hair loss is a common side effect associated with chemotherapy. However, another albeit common late side effect of cancer treatment is the abnormal swelling of one or more limbs, known as lymphedema. Lymphedema ...

Research examines over-the-counter drug's effect on chemo's side effects

September 19, 2011
New research has potential to alleviate the side effects of cancer treatments.

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.